Archive for December, 2007

Female Viagra: A Progress Report

Saturday, December 22nd, 2007

Ever since the arrival of Viagra and its explosive growth as a blockbuster drug to treat erectile dysfunction in men, there has been growing interest in a “female Viagra”. After all, it’s estimated that up to 43% of all women suffer from some form of female sexual dysfunction (FSD).

That translates into millions of women who either can’t get excited about sex, find it painful, or cannot achieve an orgasm. Most of these women (three quarters) are post menopausal but there are other reasons for FSD, including the use of anti-depressants.

So with all these women not having or not enjoying sex, the demand for some sort of Viagra for women is a marketing vacuum waiting to be filled.

Is there anything currently available that really works as a female version of Viagra (not counting all the herbal / natural aphrodisiacs of dubious effectiveness and safety)?

In 2001, there was a flurry of interest when the British Journal of Obstetrics and Gynaecology reported that women with FSD who take Viagra have more sexual fantasies, have sex more often, are more likely to enjoy it, and have far more orgasms. Although Viagra isn’t recommended for women, some doctors have been prescribing it “off label” for their female patients. (Viagra hasn’t been studied in pregnant or breast feeding women, so caution is advised.)

There was also talk of a womens Viagra cream (containing the same active ingredient as Viagra, sildenafil) that could be applied to the genital area. In early trials, it seemed to have the desired effect but has so far not made it to market.

So how does Viagra block PDE5?

Tuesday, December 11th, 2007

PDE5 is what is known as an enzyme. An enzyme is a specially folded protein that can speed up a chemical reaction. For example, the article How Cells Work describes the maltase enzyme. Maltase is shaped so that a maltose molecule can fit right in, and when it does, the maltase enzyme breaks the maltose molecule into two glucose molecules.

PDE5 is an enzyme that accepts cGMP and breaks it down. Pfizer needed a chemical that would gum up PDE5 and keep it from doing its job. The chemical that Pfizer discovered is called sildenafil citrate. It fits right into the PDE5 enzyme and disables it.

Viagra contains sildenafil citrate packaged as a pill. When a man takes a Viagra pill, the sildenafil citrate flows throughout his body, but it really only affects the PDE5 enzyme in the penis. The drug stays in the bloodstream for about four hours, and then it is washed out of the blood by the liver and kidneys.

And that’s the end of the “how it works” part of the Viagra story:

* A man takes a Viagra pill.
* The sildenafil citrate enters his bloodstream and flows throughout his body.
* The sildenafil citrate attaches to the PDE5 enzyme in his penis and disables most of it.
* When the man becomes sexually aroused, the brain sends the normal message to the NANC cells in his penis, which produce nitric oxide as usual.
* The nitric oxide creates cGMP, which starts relaxing the arteries in his penis.
* Since the PDE5 has been disabled, the cGMP in the penis does not break down. Instead, it builds up and lets the arteries in the penis fully dilate.
* His penis inflates with blood, and the man gets a full erection.